Registry data on nearly 7,000 patients with cardiogenic shock who received venous-arterial extracorporeal membrane oxygenation (VA-ECMO) provide a peek into the therapy’s real-world results across a wide range of conditions, according to the authors of a newly published research letter. Cardiogenic shock is notoriously difficult to address, partly due to its heterogeneity, Acharya said. Only last year did the Society for Cardiovascular Angiography and Interventions release the first-ever set of standardized definitions for the disease, he pointed out.
|